🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

DAY101

Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for genetically defined cancers. Their lead product candidate is DAY101, currently in Phase II clinical trials for pediatric patients with low-grade glioma.

Tags: DAY101, Pimasertib, biopharmaceuticals, cancer therapy, clinical-stage

Website

Vision/Values | Leadership | About | Contact | About | Leadership | Leadership | Leadership | Leadership | Leadership | About | About

Symbol: DAWN

Recent Price: $12.58

Industry: Biotechnology

CEO: Dr. Jeremy Bender M.B.A., Ph.D.

Sector: Healthcare

Employees: 174

Address: 395 Oyster Point Boulevard, South San Francisco, CA 94080

Phone: 650 484 0899

Leadership

  • Samuel Blackman, MD, PhD, Head of R&D
  • Elly Barry, MD, Chief Medical Officer
  • Jeremy Bender, PhD, MBA, Director
  • Davy Chiodin, PharmD, Chief Development Officer
  • Adam Dubow, General Counsel
  • Lauren Merendino, MBA, Chief Commercial Officer
  • John Stubenrauch, Chief Technology Officer
  • Jaa Roberson, Chief People Officer
  • Charles N. York II, MBA, Chief Operating and Financial Officer
  • Garry Nicholson, MBA, Chair
  • Habib Dable, Director
  • Scott Garland, Director
  • Michael Gladstone, Director
  • William Grossman, MD, PhD, Director
  • Natalie Holles, Director
  • John A. Josey, PhD, MBA, Director
  • Saira Ramasastry, MS, MPhil, Director

Last updated: 2024-12-31